↓ Skip to main content

Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, November 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
323 Dimensions

Readers on

mendeley
116 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
Published in
JNCI: Journal of the National Cancer Institute, November 2009
DOI 10.1093/jnci/djp369
Pubmed ID
Authors

Kristine R. Broglio, Donald A. Berry

Abstract

Whether progression-free survival (PFS) or overall survival (OS) is the more appropriate endpoint in clinical trials of metastatic cancer is controversial. In some disease and treatment settings, an improvement in PFS does not result in an improved OS.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 5 4%
Spain 3 3%
United Kingdom 3 3%
Australia 1 <1%
Portugal 1 <1%
United States 1 <1%
Belgium 1 <1%
Unknown 101 87%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 30%
Other 20 17%
Student > Ph. D. Student 13 11%
Professor > Associate Professor 11 9%
Unspecified 10 9%
Other 27 23%
Readers by discipline Count As %
Medicine and Dentistry 64 55%
Unspecified 20 17%
Mathematics 14 12%
Agricultural and Biological Sciences 6 5%
Economics, Econometrics and Finance 3 3%
Other 9 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2017.
All research outputs
#7,162,950
of 13,664,438 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#4,882
of 6,452 outputs
Outputs of similar age
#105,754
of 295,612 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#58
of 110 outputs
Altmetric has tracked 13,664,438 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,452 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,612 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.